4.5 Article

Reduced allele specific annexin A5 mRNA levels in placentas carrying the M2/ANXA5 allele

期刊

PLACENTA
卷 31, 期 10, 页码 937-940

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.placenta.2010.08.002

关键词

Annexin A5; ANXA5; M2 haplotype; Placenta; Pregnancy

向作者/读者索取更多资源

We aimed to trace the allele specific expression of ANXA5 mRNA in placentas carrying the M2 haplotype, conferring higher recurrent pregnancy loss risk, in order to verify directly the role of M2 in the relevant organ. The M2 allele in heterozygous placentas results in an average of 42% reduced ANXA5 mRNA levels as compared to the normal allele. Protein levels in these samples show considerable variations, impossible for statistical interpretation. The M2 allele of ANXA5 can be linked to reduced mRNA levels in heterozygous placentas and could result in more confined protein levels (lowered expression dynamics) of annexin A5. (c) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Obstetrics & Gynecology

Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state

A. D. Makatsariya, E. Slukhanchuk, V. O. Bitsadze, J. K. H. Khizroeva, M. Tretyakova, V. Tsibizova, I Elalamy, J-C Gris, E. Grandone, N. A. Makatsariya, T. Mashkova

Summary: The severe complications of COVID-19 infection involve various conditions, including thrombotic microangiopathy (TMA). This article summarizes the main types, pathogenesis, and treatment principles of TMA, and discusses the possible pathological models in patients with COVID-19.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Letter Obstetrics & Gynecology

Reply: The pathway to the 'truth' in the study of recurrent pregnancy loss and thrombophilia

Elvira Grandone, Gregory Piazza

HUMAN REPRODUCTION (2022)

Article Hematology

Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position Paper

Alessandro Squizzato, Daniela Poli, Doris Barcellona, Antonio Ciampa, Elvira Grandone, Cesare Manotti, Marco Moia, Vincenzo Toschi, Alberto Tosetto, Sophie Testa

Summary: Patients on anticoagulant treatment often need to temporarily interrupt their medication for surgeries or invasive procedures. The Italian Federation of Centers for the diagnosis of thrombotic disorders and the Surveillance of the Antithrombotic therapies (FCSA) provides practical guidance and expert opinions on assessing risks, testing, using heparin, restarting medication after high-risk bleeding surgery, and nonpharmacological suggestions for perioperative management. FCSA also suggests forming a multidisciplinary anticoagulation team for optimal management.

THROMBOSIS AND HAEMOSTASIS (2022)

Article Hematology

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

Walter Ageno, Jan Beyer Westendorf, Laura Contino, Eugenio Bucherini, Maria Teresa Sartori, Marco Senzolo, Elvira Grandone, Rita Santoro, Marc Carrier, Aurelien Delluc, Valerio De Stefano, Fulvio Pomero, Marco Paolo Donadini, Alberto Tosetto, Cecilia Becattini, Ida Martinelli, Barbara Nardo, Laurent Bertoletti, Marcello Di Nisio, Alejandro Lazo-Langner, Alessandro Schenone, Nicoletta Riva

Summary: This study evaluated the safety and efficacy of rivaroxaban as a potential alternative to standard anticoagulation for the treatment of splanchnic vein thrombosis (SVT) in non-cirrhotic patients. The results showed that rivaroxaban appeared to be a promising option for the treatment of SVT in this patient population.

BLOOD ADVANCES (2022)

Article Hematology

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

Gualtiero Palareti, Daniela Poli, Walter Ageno, Cristina Legnani, Emilia Antonucci, Eugenio Bucherini, Sophie Testa, Oriana Paoletti, Antonio Chistolini, Alessandra Serrao, Ida Martinelli, Paolo Bucciarelli, Anna Falanga, Alberto Tosetto, Luca Sarti, Daniela Mastroiacovo, Benilde Cosmi, Adriana Visona, Rita Carlotta Santoro, Nello Zanatta, Elvira Grandone, Lorenza Bertu, Vittorio Pengo, Lucia Caiano, Paolo Prandoni

Summary: This study evaluated the value of serial D-dimer testing and reduced-dose apixaban treatment in patients with unprovoked VTE. The results showed that using D-dimer testing as a basis for extending anticoagulation treatment is not accurate, and reduced-dose apixaban demonstrated high efficacy and safety in preventing recurrences.

BLOOD ADVANCES (2022)

Article Biology

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy

Pierpaolo Di Micco, Vladimir Rosa Salazar, Carmen Fernandez Capitan, Francesco Dentali, Covadonga Gomez Cuervo, Jose Luis Fernandez Torres, Jose Antonio Porras, Angeles Fidalgo, Elvira Grandone, Manuel Lopez Meseguer, Manuel Monreal

Summary: The use of rivaroxaban off-label and at low doses is associated with higher risks of major bleeding and death compared to labeled therapy, but no significant difference in venous thromboembolism recurrence was observed. Delayed initiation of rivaroxaban treatment is common in patients with severe pulmonary embolism.

LIFE-BASEL (2022)

Article Environmental Sciences

Interstitial Pregnancy Treated with Mifepristone and Methotrexate with High Serum β-hCG Level in a Patient Wishing to Preserve Fertility: Time to Define Standardized Criteria for Medical/Surgical Therapy?

Felice Sorrentino, Lorenzo Vasciaveo, Vincenzo De Feo, Erika Zanzarelli, Elvira Grandone, Guglielmo Stabile, Luigi Nappi

Summary: Interstitial pregnancy is a rare type of ectopic pregnancy, with diagnosis made by ultrasound and treatment options including medical or surgical intervention. This case report highlights the effectiveness of medical treatment, particularly for women seeking to preserve fertility. Further research is needed to establish standardized protocols and clinical scores for predicting successful outcomes in medical therapy.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Hematology

The ART of Thromboprophylaxis in the Prevention of Gestational Venous Thromboembolism

Elvira Grandone, Doris Barcellona, Mariano Intrieri, Giovanni Tiscia, Luigi Nappi, Maha Othman

Summary: This review discusses the risk of venous thromboembolism during pregnancy following ART, focusing on general and ART-specific risk factors, and provides suggestions for clinical practice based on available data and studies conducted outside ART.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Clinical Neurology

Age of onset of cerebral venous thrombosis: the BEAST study

Redoy Ranjan, Gie Ken-Dror, Ida Martinelli, Elvira Grandone, Sini Hiltunen, Erik Lindgren, Maurizio Margaglione, Veronique Le Cam Duchez, Aude Bagan Triquenot, Marialuisa Zedde, Michelangelo Mancuso, Ynte M. Ruigrok, Brad Worrall, Jennifer J. Majersik, Jukka Putaala, Elena Haapaniemi, Susanna M. Zuurbier, Matthijs C. Brouwer, Serena M. Passamonti, Maria Abbattista, Paolo Bucciarelli, Robin Lemmens, Emanuela Pappalardo, Paolo Costa, Marina Colombi, Diana Aguiar de Sousa, Sofia Rodrigues, Patricia Canhao, Aleksander Tkach, Rosa Santacroce, Giovanni Favuzzi, Antonio Arauz, Donatella Colaizzo, Kostas Spengos, Amanda Hodge, Reina Ditta, Thang S. Han, Alessandro Pezzini, Jonathan M. Coutinho, Vincent Thijs, Katarina Jood, Turgut Tatlisumak, Jose M. Ferro, Pankaj Sharma

Summary: This study aimed to determine the impact of age, gender, and risk factors on the onset of cerebral venous thrombosis (CVT). The results showed that women develop CVT 9 years earlier than men, and female patients with multiple risk factors develop CVT 12 years earlier compared to those with no identifiable risk factors.

EUROPEAN STROKE JOURNAL (2023)

Article Hematology

Contraceptives and Thrombosis: An Intertwined Revolutionary Road

Doris Barcellona, Francesco Marongiu, Elvira Grandone

Summary: The development of oral contraceptives (OCs) started in 1921 and faced challenges in understanding and managing the risk of venous thrombosis. Second-generation and later third-generation OCs were found to have increased thrombotic risk. In the 2000s, fourth-generation OCs with natural estrogens and a progestin were introduced. Research also provided insights into risk factors associated with OCs use.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Hematology

Sex-Related Differences in Patients Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study

Behnood Bikdeli, Alfonso Muriel, Yun Wang, Gregory D. Piazza, Candrika P. Khairani, Rachel Rosovsky, Ghazaleh L. Mehdipoor, Michelle O'Donoghue, Olga Madridano, Juan Bosco Lopez-Saez, Meritxell Mellado, Ana Maria Diaz Brasero, Elvira A. Grandone, Primavera Spagnolo, Yuan Lu, Laurent Bertoletti, Luciano Lopez-Jimenez, Manuel Jesus Nunez, Angeles Blanco-Molina, Marie Z. Gerhard-Herman, Samuel M. Goldhaber, Shannon Bates, David M. Jimenez, Harlan Krumholz, Manuel Monreal

Summary: Sex-specific factors play a role in the presentation of pulmonary embolism (PE) in young patients, but it is unclear if there are sex differences in older adults. Data from international and national registries show that PE is more common in elderly women. Women with PE in older age less frequently have certain comorbidities but more often have other risk factors compared to men. They also have different symptomatology, with women presenting less often with chest pain or hemoptysis but more often with dyspnea. Further investigation is needed to determine if these differences correlate with disparities in treatment and clinical outcomes.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Article Hematology

Venous thromboembolism in women of childbearing age: insights from the START registry

Elvira Grandone, Emilia Antonucci, Donatella Colaizzo, Antonio De Laurenzo, Benilde Cosmi, Michela Cini, Cristina Legnani, Sophie Testa, Maurizio Margaglione, Gualtiero Palareti

Summary: This study investigated the impact of risk factors on pregnancy- or combined oral contraceptive (COC)-associated venous thromboembolism (VTE). Results showed that family history was a significant and independent risk factor for COC-VTE and pregnancy-associated VTE. Therefore, family history plays a crucial role in predicting the occurrence of VTE in the context of pregnancy or COC use.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Medicine, General & Internal

Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents

Carlo Rostagno, Gaia Rubbieri, Mattia Zeppa, Alessandro Cartei, Alice Ceccofiglio, Giulio Maria Mannarino, Gualtiero Palareti, Elvira Grandone

Summary: This study aimed to investigate the perioperative management and long-term prognosis of elderly patients undergoing urgent hip surgery while receiving antithrombotic treatment. The study found that anticoagulants may delay surgery, but a delay of more than 48 hours does not have a significant impact on prognosis. Patients receiving warfarin had a lower one-year survival rate, potentially due to their higher risk profile at the time of trauma.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Hematology

Blood supply, transfusion demand and mortality in Italian patients hospitalised during nine months of COVID-19 pandemic

Elvira Grandone, Mario Mastroianno, Lazzaro di Mauro, Antonella Caroli, Giovanni Tiscia, Angelo Ostuni

Summary: During the COVID-19 pandemic in 2020 in Italy, there was a significant decrease in blood donations and transfusions, along with an increase in fatality rate among male patients. Patterns of blood transfusion and mortality among COVID-19 patients show certain trends that require attention and management.

BLOOD TRANSFUSION (2022)

暂无数据